Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06579209 · ClinicalTrials.gov registry record · NA
NAD+ Oral Supplement Pilot Intervention in Adult Females
A NA study, sponsored by University of Rhode Island.
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
NCT06579209 is a NA study that has completed, run by University of Rhode Island. The registered enrollment target is 53 participants.
The verdict
NCT06579209, a NA study, has completed, sponsored by University of Rhode Island.
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn whether Nicotinamide adenine dinucleotide (NAD+) can influence cognition and biomarkers in healthy, cognitively intact women aged 40-80. The main questions it aims to answer are: Will cognitive functioning change in response to NAD+? Will inflammatory markers and serum indicators of neurodegeneration change in response to NAD+? Researchers will compare individuals receiving NAD+ to those receiving placebo to see if the results differ. Participants will: Complete an online questionnaire, Visit the lab for computerized cognitive testing and a blood draw, Take NAD+ or a placebo every day for 4 weeks, Visit the lab for computerized cognitive testing and a blood draw
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2024-12-01 |
| Est. Completion | 2026-02-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06579209
The ClinicalTrials.gov registry entry for NCT06579209 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rhode Island, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT06579209 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06579209 about?
NCT06579209 is a clinical study titled "NAD+ Oral Supplement Pilot Intervention in Adult Females". The goal of this clinical trial is to learn whether Nicotinamide adenine dinucleotide (NAD+) can influence cognition and biomarkers in healthy, cognitively intact women aged 40-80. The main questions it aims to answer are: Will cognitive functioning change in response to NAD+? Will inflammatory mar...
What is the current status of trial NCT06579209?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2024-12-01. Estimated completion is 2026-02-20.
What interventions are being tested in trial NCT06579209?
The interventions under investigation include: Placebo (OTHER), Treatment (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06579209?
This trial is sponsored by University of Rhode Island, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.